Imatinib for treating newly diagnosed chronic myeloid leukemia patients

Article

Abstract: This is the protocol for a review and there is no abstract. The objectives are as follows: To assess

Palabras claves:

Autores:

Acevedo A.M., Anand V., Cardona A.F., Daniel Simancas-Racines, Gupta P., Prof. Arturo Martí Carvajal MD MSc Ph.D iD, Sola I.

Fuentes:

scopus